This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty ...

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

Silver Spring, MD - The US Food and Drug Administration (FDA) has approved the first generic formulations of losartan potassium tablets, alone (Cozaar, Merck) and in combination with ...

The metabolic syndrome represents a specific cluster of phenotypes that increase the risk for coronary heart disease and type-2 diabetes mellitus. 1, 2, 3, 4 Owing to ...

Patients with severe hypertension are at high risk for cardiovascular events. The authors hypothesized that initial treatment with a combination angiotensin receptor blocker/diuretic agent would be ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...

Multiple lots of drugs containing the active ingredient Losartan are being voluntarily recalled by the manufacturers, according to Health Canada, because they might contain a potential human ...

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens. July 13, ...

OTTAWA, March 9, 2019 /CNW/ - Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and ...

Torrent Pharmaceuticals has expanded its voluntary recall of its losartan potassium tablets to include five additional lots due to unacceptable amounts of N-Nitroso-N-methyl-4-aminobutyric acid, or ...